Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Iscience|February 22, 2023
Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 geneKosuke Takada, Mahoko Takahashi Ueda, Shintaro Shichinohe, et al.Journal of Virology|April 16, 2024
Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolutionKosuke Takada, Yasuko Orba, Yurie Kida, et al.The Journal of General Virology|August 20, 2019
Long-term culture of human lung adenocarcinoma A549 cells enhances the replication of human influenza A virusesMichiko Ujie, Kosuke Takada, Maki Kiso, et al.Iscience|February 26, 2026
Broad-spectrum antiviral activity of antisense oligonucleotides targeting GBF1 against SARS-CoV-2 and influenza virusesVictoria Simanihuruk, Yurie Kida, Kosuke Takada, et al.Microbiology Spectrum|November 26, 2025
Characterization of H5N1 high pathogenicity avian influenza virus belonging to clade 2.3.4.4b isolated from Ezo red fox in Japan in a mouse modelShintaro Shichinohe, Takahiro Hiono, Yasushi Itoh, et al.Mbio|February 10, 2021
Plasticity of the Influenza Virus H5 HA ProteinHuihui Kong, David F Burke, Tiago Jose da Silva Lopes, et al.Microbiology Spectrum|February 28, 2024
Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domainItsuki Anzai, Junso Fujita, Chikako Ono, et al.Nature Microbiology|May 1, 2019
A humanized MDCK cell line for the efficient isolation and propagation of human influenza virusesKosuke Takada, Chiharu Kawakami, Shufang Fan, et al.Nature Microbiology|November 27, 2019
Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory dropletsMasaki Imai, Makoto Yamashita, Yuko Sakai-Tagawa, et al.Proceedings of the National Academy of Sciences of the United States of America|June 24, 2020
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure developmentMasaki Imai, Kiyoko Iwatsuki-Horimoto, Masato Hatta, et al.Pageof 3